Investigational Site Number : 7030003

Banská Bystrica 975 17

1 studies enrolling now · 2 studies all time

What they study most

Colitis Ulcerative, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease — Recruiting now
• Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis — Running, not enrolling